Geode Capital Management
DERM icon

Geode Capital Management’s Journey Medical DERM Stock Holding History

Geode Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Sell
216,004
-247,198
-53% -$1.41M ﹤0.01% 3250
2026
Q1 		$2.17M Buy
463,202
+149,232
+48% +$1.16M ﹤0.01% 3086
2025
Q4 		$2.42M Buy
313,970
+36,124
+13% +$283K ﹤0.01% 3097
2025
Q3 		$1.98M Buy
277,846
+15,493
+6% +$112K ﹤0.01% 3184
2025
Q2 		$1.88M Buy
262,353
+148,612
+131% +$1.03M ﹤0.01% 3166
2025
Q1 		$671K Buy
113,741
+4,525
+4% +$22.2K ﹤0.01% 3438
2024
Q4 		$427K Buy
109,216
+781
+0.7% +$4.27K ﹤0.01% 3654
2024
Q3 		$613K Buy
108,435
+12,882
+13% +$66.3K ﹤0.01% 3529
2024
Q2 		$539K Buy
95,553
+6,478
+7% +$26.7K ﹤0.01% 3544
2024
Q1 		$328K Buy
89,075
+3,290
+4% +$14.3K ﹤0.01% 3767
2023
Q4 		$494K Buy
85,785
+16,276
+23% +$72.5K ﹤0.01% 3615
2023
Q3 		$191K Buy
69,509
+40,015
+136% +$89.4K ﹤0.01% 4002
2023
Q2 		$46.9K Hold
29,494
– – ﹤0.01% 4516
2023
Q1 		$46.3K Sell
29,494
-438
-1% -$817 ﹤0.01% 4537
2022
Q4 		$57K Buy
29,932
+2,377
+9% +$4.7K ﹤0.01% 4556
2022
Q3 		$67K Buy
+27,555
New +$93.9K ﹤0.01% 4700

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management's DERM Position: Q2 2026 in Review

Geode Capital Management reduced its Journey Medical (DERM) stake by 53% in Q2 2026, selling an estimated $1.41M and leaving 216,004 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3250.

Geode Capital Management first reported a position in DERM in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.42M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Geode Capital Management held 216,004 shares of Journey Medical worth $1.53M as of Q2 2026.
  • Geode Capital Management sold 247,198 Journey Medical shares in Q2 2026, an estimated $1.41M.
  • Journey Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3250 holding.
  • Geode Capital Management first reported a position in Journey Medical in Q3 2022 and has held it in 16 quarters since.
  • Geode Capital Management's Journey Medical position peaked at $2.42M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.